Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-137749

Published: 2020

Journal Articles

Secondary Graft-Versus-Host Disease (GVHD) Prophylaxis with Oral Proteasome Inhibitor Ixazomib Is Associated with Low Incidence of Recurrent, Late Acute and Chronic GVHD and Facilitated Calcineurin Inhibitor Taper within the First Year Post Allogeneic Stem Cell Transplantation

Natasia Rodriguez, BSN, Jasme Lee, Lisa Flynn, Fiona Murray, Sean Devlin, PhD, Cristina Soto Izquierdo, Christina Cho, MD, Parastoo B. Dahi, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD, Miguel-Angel Perales, MD, Doris M Ponce, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139666

Published: 2020

Journal Articles

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

Doris M Ponce, MD, Marina D Burgos da Silva, PhD, Antonio L.C. Gomes, PhD, Gillian Moore, BA, John B. Slingerland, BSc, Eric G. Pamer, MD, Ying Taur, MD MPH, Jonathan U. Peled, MD PhD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 4538.

https://doi.org/10.1182/blood-2019-131067

Published: 2019

Journal Articles

Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic Transplantation

Paola Vinci, PhD, Elena Garcia-Martinez, MD, Margaret H. O'Connor, Anastasiya Egorova, Jason Kuttiyara, Viktor Arnhold, MD, Doris M Ponce, MD, Alan M. Hanash, MD PhD

Blood (2019) 134 (Supplement_1): 3204.

https://doi.org/10.1182/blood-2019-128966

Published: 2019

Journal Articles

Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience

Zachary D. Epstein-Peterson, MD, Paola Ghione, MD, Alison J. Moskowitz, MD, Parastoo B. Dahi, MD, Ahmet Dogan, MD PhD, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, Miguel-Angel Perales, MD, Doris M Ponce, MD, David J. Straus, MD, Andrew D. Zelenetz, MD PhD, Craig S. Sauter, MD, Steven M. Horwitz, MD

Blood (2019) 134 (Supplement_1): 2850.

https://doi.org/10.1182/blood-2019-125376

Published: 2019

Journal Articles

Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

Blood (2019) 134 (Supplement_1): 3264.

https://doi.org/10.1182/blood-2019-124902

Published: 2019

Journal Articles

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Christina Cho, MD, Patrick Hilden, MS, Jonathan U. Peled, MD PhD, Scott T. Avecilla, MD PhD, Pere Barba, MD, Juliet N. Barker, MBBS (Hons), Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Guenther Koehne, MD PhD, Richard C. Meagher, PhD, Molly A. Maloy, MS, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Doris M. Ponce, MD, Marcel R. M. van den Brink, MD PhD, James W. Young, MD, Miguel-Angel Perales, MD

Blood (2016) 128 (22): 3498.

https://doi.org/10.1182/blood.V128.22.3498.3498

Published: 2016

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

Journal Articles

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Ioannis Politikos, MD, Sean Devlin, PhD, Yeon Yoo, BS, Christopher Mazis, BS, Molly A. Maloy, MS, Andromachi Scaradavou, MD, Parastoo B. Dahi, MD, Miguel Perales, MD, Sergio Giralt, MD, Doris M Ponce, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2193.

https://doi.org/10.1182/blood.V128.22.2193.2193

Published: 2016

Journal Articles

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

Kirsten Boughan, MD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Courtney Byam, BS, CHTC, Yeon Yoo, BS, Christopher Mazis, BS, Eric Davis, CHTC, Melissa Nhaissi, MPH, Jennifer Paulson, MBS, CHTC, Deborah Wells, MA, CHTC, Candice Cooper, BS, Doris M Ponce, MD, Sergio Giralt, MD, Esperanza B. Papadopoulos, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 821.

https://doi.org/10.1182/blood.V128.22.821.821

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Bartlomiej Getta, MBBS,, Ashwin Kishtagari, MD, Patrick Hilden, MS, Sean Devlin, PhD, Molly A. Maloy, MS, Patrick K. Gonzales, Brian C. Shaffer, MD, Doris M Ponce, MD, Boglarka Gyurkocza, MD, Juliet N. Barker, MBBS, Esperanza B. Papadopoulos, MD, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, James W. Young, MD, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Virginia M. Klimek, MD

Blood (2016) 128 (22): 3188.

https://doi.org/10.1182/blood.V128.22.3188.3188

Published: 2016

Journal Articles

Prospective Evaluation of Cord Blood (CB) & Haplo-Identical Donor Availability Reveals Compromised Donor Access for Both Graft Types in Minorities and High Rates of Failure to Clear Haplo Donors in Adult Patients

Satyajit Kosuri, MD, Tara F. Wolff, MS, NP-BC, Courtney Byam, BS, CHTC, Emily Lauer, BS, BA, Yeon Yoo, BS, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Andromachi Scaradavou, MD, Doris M Ponce, MD, Juliet N. Barker, MBBS (Hons)

Blood (2015) 126 (23): 2027.

https://doi.org/10.1182/blood.V126.23.2027.2027

Published: 2015

Journal Articles

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Blood (2015) 126 (23): 4332.

https://doi.org/10.1182/blood.V126.23.4332.4332

Published: 2015

Journal Articles

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Blood (2015) 126 (23): 3231.

https://doi.org/10.1182/blood.V126.23.3231.3231

Published: 2015

Journal Articles

Impact of Busulphan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndromes Undergoing CD34 Selected Allogeneic Hematopoietic Cell Transplantation

Roni Tamari, MD, Proli Anthony, Pharm-D, Juntig Zheng, MS, Ann A. Jakubowski, MD PhD, Esperanza B Papadopoulos, MD, Doris M Ponce, MD, Sean Devlin, PhD, Craig S. Sauter, MD, James W. Young, MD, Sergio A. Giralt, MD, H.R. Castro-Malaspina, MD

Blood (2015) 126 (23): 1911.

https://doi.org/10.1182/blood.V126.23.1911.1911

Published: 2015

Journal Articles

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Duncan Purtill, FRACP,FRCPA,MBBS, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Miguel-Angel Perales, MD, Richard J O'Reilly, MD, Marcel Van Den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2459.

https://doi.org/10.1182/blood.V124.21.2459.2459

Published: 2014

Journal Articles

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

Doris M. Ponce, MD, Patrick Hilden, MS, Sean M. Devlin, PhD, Molly Maloy, MA, Marissa N Lubin, BA, H.R. Castro-Malaspina, MD, Jenna D Goldberg, MD, Ann A. Jakubowski, MD PhD, Richard Meagher, PhD, Esperanza B Papadopoulos, MD, Miguel-Angel Perales, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Nancy A. Kernan, MD, Richard J O'Reilly, MD, Andromachi Scaradavou, MD, Sergio Giralt, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2588.

https://doi.org/10.1182/blood.V124.21.2588.2588

Published: 2014

Journal Articles

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Susan E. Prockop, MD, Aisha Hasan, MD, Guenther Koehne, MD PhD, Ekaterina Doubrovina, MD PhD, Craig S. Sauter, MD, Juliet N, Barker, MBBS, Karim Baroudy, Farid Boulad, MD, Sergio Giralt, MD, Ramzi Khalaf, Nancy A. Kernan, MD, Esperanza B Papadopoulos, MD, Doris M. Ponce, MD, Andromachi Scaradavou, MD, Stephanie Suser, Gloria Wasilewski, RN, Richard J. O'Reilly, MD

Blood (2014) 124 (21): 184.

https://doi.org/10.1182/blood.V124.21.184.184

Published: 2014

Journal Articles

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Duncan Purtill, FRACP,FRCPA,MBBS, Doris M. Ponce, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Parastoo B Dahi, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Richard J. O'Reilly, MD, Marcel R.M. van den Brink, MD PhD, James W. Young, MD, Andromachi Scaradavou, MD, Cladd Stevens, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1156.

https://doi.org/10.1182/blood.V124.21.1156.1156

Published: 2014

Journal Articles

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Parastoo B Dahi, MD, Craig S. Sauter, MD, Sean M. Devlin, PhD, Marissa N Lubin, BA, Doris M. Ponce, MD, Sergio Giralt, MD, Guenther Koehne, MD PhD, Miguel-Angel Perales, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 1258.

https://doi.org/10.1182/blood.V124.21.1258.1258

Published: 2014

NARROW

Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy

Secondary Graft-Versus-Host Disease (GVHD) Prophylaxis with Oral Proteasome Inhibitor Ixazomib Is Associated with Low Incidence of Recurrent, Late Acute and Chronic GVHD and Facilitated Calcineurin Inhibitor Taper within the First Year Post Allogeneic Stem Cell Transplantation

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic Transplantation

Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience

Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Prospective Evaluation of Cord Blood (CB) & Haplo-Identical Donor Availability Reveals Compromised Donor Access for Both Graft Types in Minorities and High Rates of Failure to Clear Haplo Donors in Adult Patients

Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Impact of Busulphan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndromes Undergoing CD34 Selected Allogeneic Hematopoietic Cell Transplantation

Analysis of 129 Myeloablative Double-Unit Cord Blood Transplantation Recipients Demonstrates an Independent Association Between Non-Dominant Unit TNC Dose and Engraftment Suggesting a Facilitation Effect

Disease-Free Survival in Adult Patients with Acute Leukemia and Advanced CML Supports Use of Double-Unit Cord Blood Grafts As an Immediate Alternative to 8/8 HLA-Matched Unrelated Donors (URD)

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Day 45 Lymphocyte Recovery Is Independently Associated with Transplant-Related Mortality after Adult Myeloablative Double-Unit Cord Blood Transplantation (dCBT)

Successful Salvage of High-Risk B-Cell Non-Hodgkin and Hodgkin Lymphoma with Double-Unit Cord Blood Transplantation Provides a Platform for Further Optimization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only